Showing 1 - 20 results of 229,279 for search '(((( 59 ((mean decrease) OR (_ decrease)) ) OR ( a a decrease ))) OR ( 2 d decrease ))*', query time: 1.63s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…<b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”
  7. 7
  8. 8

    Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

    Published 2018
    “…<p></p><p>Abstract Purpose: To demonstrate the efficacy of 0.025% atropine eyedrops in myopic children in Brazil for decreasing myopia progression Methods: This was a prospective study with 60 children from Hospital Geral Universitário and Oftalmocenter Santa Rosa in Cuiabá, MT, Brazil, aged between 6 to 12 years, with spherical equivalent refractive error of -1.00 to -6.00 diopters (D) and astigmatism of -1.00 D or smaller. …”
  9. 9
  10. 10
  11. 11

    HDM exposure results in increased MIP-2 and decreased IFNα and IL-13. by Jennifer A. Phan (535730)

    Published 2014
    “…HDM exposure increased bronchoalveolar lavage MIP-2 (A), and decreased IFNα (B) and IL13 (C). There was no effect of HDM exposure on BAL protein (D), nor were there any effects of HRV-1B infection alone, or combined effects of HDM exposure and HRV-1B infection on any of these parameters. * indicates a significant difference between groups. …”
  12. 12
  13. 13

    IL-35 decreased the prevalence of Th17 in CD4+ T cells. by Yin Zongyi (3111660)

    Published 2017
    “…<p>(A)The ratio of Th17 in CD4+ T cells. (B) Representative diagram showing Th17’s ratio in CD4+ T cells was significantly decreased in the IL-35 group compared to that in the control group (0.3% vs. 7.2% on day 5, P<0.01). …”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20